Company / Operating Cash Flow per Share
Beta Bionics, Inc. Operating Cash Flow per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$7.64
FY2025
5-year range
-$9.10 / -$6.12
FY2023-FY2025
Trend
+16.1%
vs FY2024
Sector context
#159 of 161
Health Care
What the data says
Among 161 Health Care companies, Beta Bionics, Inc. is in the bottom 1% for operating cash flow per share. Declined from $-6.12 to $-7.64 over the past 2 years.
Based on SEC 10-K filings.
-7.64 in FY2025.
Declined from $-6.12 to $-7.64 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 161This company -$7.64 Sector average $6.67
▼
-214.5% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 16.1% year-over-year.
- Ranks #159 out of 161 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$7.64 | +16.1% |
| FY2024 | -$9.10 | -48.8% |
| FY2023 | -$6.12 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026